Clinical Trial

The FLOW Registry.

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to create a database and prospective registry for data collection on patients with benign prostatic hyperplasia undergoing Aquablation of the prostate. All patients undergoing Aquablation of the prostate will be enrolled in the registry. Historical data from 1/1/2024- 11/30/2025 will be added through chart review. Current and future patient data will be collected through chart review during the subject's clinical care. Only data available in the electronic medical record will be collected and no additional data will be collected for research purposes. No biospecimens will be collected, and there are no physical risks from study participation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-02-18; most recent amendment 2026-07-06.
Trial Details
NCT Number NCT07430423
Lead Sponsor University of Chicago
Conditions Benign Prostatic Hyperplasia (BPH)
Enrollment 3,000 participants
Start Date 2026-08
Primary Completion 2036-12 (estimated)
Study Completion 2036-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-07